HER2 neu

Results: 387



#Item
51South Africa 20 years post-democracy: what place for personalised health care? Kathleen Kahn MRC/Wits Rural Public Health & Health Transitions Research Unit School of Pubic Health University of the Witwatersrand

South Africa 20 years post-democracy: what place for personalised health care? Kathleen Kahn MRC/Wits Rural Public Health & Health Transitions Research Unit School of Pubic Health University of the Witwatersrand

Add to Reading List

Source URL: www.swisstph.ch

Language: English - Date: 2014-12-17 06:18:31
52Perez et al. Breast Cancer Research 2014, 16:R50 http://breast-cancer-research.com/content/16/3/R50 RESEARCH ARTICLE Open Access

Perez et al. Breast Cancer Research 2014, 16:R50 http://breast-cancer-research.com/content/16/3/R50 RESEARCH ARTICLE Open Access

Add to Reading List

Source URL: breast-cancer-research.com

Language: English
53Barok et al. Breast Cancer Research 2014, 16:209 http://breast-cancer-research.com/contentREVIEW Trastuzumab emtansine: mechanisms of action

Barok et al. Breast Cancer Research 2014, 16:209 http://breast-cancer-research.com/contentREVIEW Trastuzumab emtansine: mechanisms of action

Add to Reading List

Source URL: breast-cancer-research.com

Language: English
54Breast Cancer Data Definitions for the National Minimum Core Dataset to Support the Introduction of Breast Quality Performance Indicators Definitions developed by ISD Scotland in collaboration with the Breast Quality Per

Breast Cancer Data Definitions for the National Minimum Core Dataset to Support the Introduction of Breast Quality Performance Indicators Definitions developed by ISD Scotland in collaboration with the Breast Quality Per

Add to Reading List

Source URL: www.isdscotland.org

Language: English - Date: 2014-12-08 07:49:00
55Ribbon symbolism / Oncotype DX / Breast cancer / Tamoxifen / Adjuvant therapy / HER2/neu / Chemotherapy / Medicine / Cancer treatments / Oncology

MSAC Public Summary Document Application No[removed]Gene expression profiling of 21 genes in breast cancer to quantify the risk of disease recurrence and predict adjuvant chemotherapy benefit

Add to Reading List

Source URL: www.msac.gov.au

Language: English - Date: 2015-04-16 01:49:35
56

PDF Document

Add to Reading List

Source URL: www.ootr.org

Language: English - Date: 2013-04-17 00:15:35
579th conf_web banner_revised2

9th conf_web banner_revised2

Add to Reading List

Source URL: www.ootr.org

Language: English - Date: 2013-03-28 03:27:50
58Health Care in the Era of Personalized Medicine: An Industry Perspective Andreas Wallnoefer Pharma Research & Early Development F. Hoffmann-La Roche Ltd.

Health Care in the Era of Personalized Medicine: An Industry Perspective Andreas Wallnoefer Pharma Research & Early Development F. Hoffmann-La Roche Ltd.

Add to Reading List

Source URL: www.swisstph.ch

Language: English - Date: 2014-12-17 06:35:36
59Trastuzumab (Herceptin) Factsheet This factsheet explains what trastuzumab is, how it works, when it may be given, its benefits and the possible side effects.

Trastuzumab (Herceptin) Factsheet This factsheet explains what trastuzumab is, how it works, when it may be given, its benefits and the possible side effects.

Add to Reading List

Source URL: www2.breastcancercare.org.uk

Language: English - Date: 2015-03-27 11:51:24
60POST-CONFERENCE NEWSLETTER - APRIL 14, 2014 Editorial Translation of International Sponsored Trial Results to Clinical Practice in Asia: The Hurdles and Challenges ARLENE CHAN, MB BS, FRACP, MMED

POST-CONFERENCE NEWSLETTER - APRIL 14, 2014 Editorial Translation of International Sponsored Trial Results to Clinical Practice in Asia: The Hurdles and Challenges ARLENE CHAN, MB BS, FRACP, MMED

Add to Reading List

Source URL: www.ootr.org

Language: English - Date: 2014-07-30 00:10:28